Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kiyotaka Kawashima

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Urologia Internationalis|March 8, 2013
Salvage I seed implantation for prostate cancer with postradiation local recurrenceMasaki Shimbo, Koichi Inoue, Yusuke Koike, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|July 23, 2019
[PROSTATE CANCER DETECTION ON INITIAL TRANSRECTAL PROSTATE BIOPSY IN RELATION TO PROSTATE-SPECIFIC ANTIGEN LEVELS]Tetsuya Makino, Yuma Sakura, Kentaro Goto, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|December 21, 2005
[Prognostic factors for PSA relapse of prostate cancer after endocrine therapy]Seiji Nakata, Katsuya Nakano, Hirotomo Takahashi, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|October 19, 2002
[PSA-related parameters in prostate cancer relapsed after endocrine therapy]Seiji Nakata, Hirotomo Takahashi, Yutaka Takezawa, et al.
Photochemistry and Photobiology|March 27, 2009
siRNA-mediated knockdown of the heme synthesis and degradation pathways: modulation of treatment effect of 5-aminolevulinic acid-based photodynamic therapy in urothelial cancer cell linesMakito Miyake, Masazumi Ishii, Kiyotaka Kawashima, et al.
Digestive Surgery|May 22, 2003
Curative surgery for local pelvic recurrence of rectal cancerNorio Saito, Keiji Koda, Nobuhiro Takiguchi, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 4, 2009
1-tert-butyl-3-[6-(3,5-dimethoxy-phenyl)-2-(4-diethylamino-butylamino)-pyrido[2,3-d]pyrimidin-7-yl]-urea (PD173074), a selective tyrosine kinase inhibitor of fibroblast growth factor receptor-3 (FGFR3), inhibits cell proliferation of bladder cancer carrying the FGFR3 gene mutation along with up-regulation of p27/Kip1 and G1/G0 arrestMakito Miyake, Masazumi Ishii, Naoki Koyama, et al.
World Journal of Gastroenterology|August 27, 2005
Pneumoscrotum: a rare manifestation of perforation associated with therapeutic colonoscopyKuang-I Fu, Yasushi Sano, Shigeharu Kato, et al.
BMC Cancer|June 6, 2013
Diagnostic markers of urothelial cancer based on DNA methylation analysisYoshitomo Chihara, Yae Kanai, Hiroyuki Fujimoto, et al.
Biochemical and Biophysical Research Communications|September 7, 2007
Sensitive detection of FGFR3 mutations in bladder cancer and urine sediments by peptide nucleic acid-mediated real-time PCR clampingMakito Miyake, Kokichi Sugano, Kiyotaka Kawashima, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Urologia Internationalis|March 8, 2013
Salvage I seed implantation for prostate cancer with postradiation local recurrenceMasaki Shimbo, Koichi Inoue, Yusuke Koike, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|July 23, 2019
[PROSTATE CANCER DETECTION ON INITIAL TRANSRECTAL PROSTATE BIOPSY IN RELATION TO PROSTATE-SPECIFIC ANTIGEN LEVELS]Tetsuya Makino, Yuma Sakura, Kentaro Goto, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|December 21, 2005
[Prognostic factors for PSA relapse of prostate cancer after endocrine therapy]Seiji Nakata, Katsuya Nakano, Hirotomo Takahashi, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|October 19, 2002
[PSA-related parameters in prostate cancer relapsed after endocrine therapy]Seiji Nakata, Hirotomo Takahashi, Yutaka Takezawa, et al.
Photochemistry and Photobiology|March 27, 2009
siRNA-mediated knockdown of the heme synthesis and degradation pathways: modulation of treatment effect of 5-aminolevulinic acid-based photodynamic therapy in urothelial cancer cell linesMakito Miyake, Masazumi Ishii, Kiyotaka Kawashima, et al.
Digestive Surgery|May 22, 2003
Curative surgery for local pelvic recurrence of rectal cancerNorio Saito, Keiji Koda, Nobuhiro Takiguchi, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 4, 2009
1-tert-butyl-3-[6-(3,5-dimethoxy-phenyl)-2-(4-diethylamino-butylamino)-pyrido[2,3-d]pyrimidin-7-yl]-urea (PD173074), a selective tyrosine kinase inhibitor of fibroblast growth factor receptor-3 (FGFR3), inhibits cell proliferation of bladder cancer carrying the FGFR3 gene mutation along with up-regulation of p27/Kip1 and G1/G0 arrestMakito Miyake, Masazumi Ishii, Naoki Koyama, et al.
World Journal of Gastroenterology|August 27, 2005
Pneumoscrotum: a rare manifestation of perforation associated with therapeutic colonoscopyKuang-I Fu, Yasushi Sano, Shigeharu Kato, et al.
BMC Cancer|June 6, 2013
Diagnostic markers of urothelial cancer based on DNA methylation analysisYoshitomo Chihara, Yae Kanai, Hiroyuki Fujimoto, et al.
Biochemical and Biophysical Research Communications|September 7, 2007
Sensitive detection of FGFR3 mutations in bladder cancer and urine sediments by peptide nucleic acid-mediated real-time PCR clampingMakito Miyake, Kokichi Sugano, Kiyotaka Kawashima, et al.
Pageof 2